|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goldstraw P, Ball D, Jett JR, Le Chevalier
T, Lim E, Nicholson AG and Shepherd FA: Non-small-cell lung cancer.
Lancet. 378:1727–1740. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang M, Lewinska M, Fan X, Zhu J and Yuan
ZM: PRR14 is a novel activator of the PI3K pathway promoting lung
carcinogenesis. Oncogene. 35:5527–5538. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Blume-Jensen P and Hunter T: Oncogenic
kinase signalling. Nature. 411:355–365. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ullrich A and Schlessinger J: Signal
transduction by receptors with tyrosine kinase activity. Cell.
61:203–212. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lemmon MA and Schlessinger J: Cell
signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Berger AH, Niki M, Morotti A, Taylor BS,
Socci ND, Viale A, Brennan C, Szoke J, Motoi N, Rothman PB, et al:
Identification of DOK genes as lung tumor suppressors. Nat Genet.
42:216–223. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Simister PC and Feller SM: Order and
disorder in large multi-site docking proteins of the Gab
family–implications for signalling complex formation and inhibitor
design strategies. Mol Biosyst. 8:33–46. 2012. View Article : Google Scholar
|
|
9
|
Jones N and Dumont DJ: Recruitment of
Dok-R to the EGF receptor through its PTB domain is required for
attenuation of Erk MAP kinase activation. Curr Biol. 9:1057–1060.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bedirian A, Baldwin C, Abe J, Takano T and
Lemay S: Pleckstrin homology and phosphotyrosine-binding
domain-dependent membrane association and tyrosine phosphorylation
of Dok-4, an inhibitory adapter molecule expressed in epithelial
cells. J Biol Chem. 279:19335–19349. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mashima R, Honda K, Yang Y, Morita Y,
Inoue A, Arimura S, Nishina H, Ema H, Nakauchi H, Seed B, et al:
Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive
histiocytic sarcoma. Lab Invest. 90:1357–1364. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Crowder RJ, Enomoto H, Yang M, Johnson EM
Jr and Milbrandt J: Dok-6, a Novel p62 Dok family member, promotes
Ret-mediated neurite outgrowth. J Biol Chem. 279:42072–42081. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grimm J, Sachs M, Britsch S, Di Cesare S,
Schwarz-Romond T, Alitalo K and Birchmeier W: Novel p62dok family
members, dok-4 and dok-5, are substrates of the c-Ret receptor
tyrosine kinase and mediate neuronal differentiation. J Cell Biol.
154:345–354. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cossins J, Liu WW, Belaya K, Maxwell S,
Oldridge M, Lester T, Robb S and Beeson D: The spectrum of
mutations that underlie the neuromuscular junction synaptopathy in
DOK7 congenital myasthenic syndrome. Hum Mol Genet. 21:3765–3775.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
An CH, Kim MS, Yoo NJ and Lee SH:
Mutational and expressional analysis of a haploinsufficient tumor
suppressor gene DOK2 in gastric and colorectal cancers. APMIS.
119:562–564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miyagaki H, Yamasaki M, Takahashi T,
Kurokawa Y, Miyata H, Nakajima K, Takiguchi S, Fujiwara Y, Mori M
and Doki Y: DOK2 as a marker of poor prognosis of patients with
gastric adenocarcinoma after curative resection. Ann Surg Oncol.
19:1560–1567. 2012. View Article : Google Scholar
|
|
17
|
Yamanashi Y, Higuch O and Beeson D:
Dok-7/MuSK signaling and a congenital myasthenic syndrome. Acta
Myol. 27:25–29. 2008.PubMed/NCBI
|
|
18
|
Okada K, Inoue A, Okada M, Murata Y,
Kakuta S, Jigami T, Kubo S, Shiraishi H, Eguchi K, Motomura M, et
al: The muscle protein Dok-7 is essential for neuromuscular
synaptogenesis. Science. 312:1802–1805. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang SM, Li SY, Yu HB, Li JR and Sun LL:
Repression of DOK7 mediated by DNMT3A promotes the proliferation
and invasion of KYSE410 and TE-12 ESCC cells. Biomed Pharmacother.
90:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hamuro J, Higuchi O, Okada K, Ueno M,
Iemura S, Natsume T, Spearman H, Beeson D and Yamanashi Y:
Mutations causing DOK7 congenital myasthenia ablate functional
motifs in Dok-7. J Biol Chem. 283:5518–5524. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hallock PT, Xu CF, Park TJ, Neubert TA,
Curran T and Burden SJ: Dok-7 regulates neuromuscular synapse
formation by recruiting Crk and Crk-L. Genes Dev. 24:2451–2461.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mayer BJ, Ren R, Clark KL and Baltimore D:
A putative modular domain present in diverse signaling proteins.
Cell. 73:629–630. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pawson T: Protein modules and signalling
networks. Nature. 373:573–580. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saraste M and Hyvönen M: Pleckstrin
homology domains: A fact file. Curr Opin Struct Biol. 5:403–408.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen G, Yu H, Satherley L, Zabkiewicz C,
Resaul J, Zhao H, Mu H, Zhi X, He J, Ye L, et al: The downstream of
tyrosine kinase 7 is reduced in lung cancer and is associated with
poor survival of patients with lung cancer. Oncol Rep.
37:2695–2701. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao H, Yu H, Martin TA, Zhang Y, Chen G
and Jiang WG: Effect of junctional adhesion molecule-2 expression
on cell growth, invasion and migration in human colorectal cancer.
Int J Oncol. 48:929–936. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Berger AH, Chen M, Morotti A, Janas JA,
Niki M, Bronson RT, Taylor BS, Ladanyi M, Van Aelst L, Politi K, et
al: DOK2 inhibits EGFR-mutated lung adenocarcinoma. PLoS One.
8:e795262013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bergamin E, Hallock PT, Burden SJ and
Hubbard SR: The cytoplasmic adaptor protein Dok7 activates the
receptor tyrosine kinase MuSK via dimerization. Mol Cell.
39:100–109. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Buyan A, Kalli AC and Sansom MS:
Multiscale Simulations Suggest a Mechanism for the Association of
the Dok 7 PH Domain with PIP-Containing Membranes. PLOS Comput
Biol. 12:e10050282016. View Article : Google Scholar
|
|
30
|
Chen QY and Costa M: PI3K/Akt/mTOR
Signaling Pathway and the Biphasic Effect of Arsenic in
Carcinogenesis. Mol Pharmacol. 94:784–792. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi H, Pu J, Zhou XL, Ning YY and Bai C:
Silencing long non-coding RNA ROR improves sensitivity of
non-small-cell lung cancer to cisplatin resistance by inhibiting
PI3K/Akt/mTOR signaling pathway. Tumour Biol.
39:10104283176975682017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu J, Yao J, Huang R, Wang Y, Jia M and
Huang Y: Ghrelin promotes human non-small cell lung cancer A549
cell proliferation through PI3K/Akt/mTOR/P70S6K and ERK signaling
pathways. Biochem Biophys Res Commun. 498:616–620. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lv X, Li CY, Han P and Xu XY:
MicroRNA-520a-3p inhibits cell growth and metastasis of non-small
cell lung cancer through PI3K/AKT/mTOR signaling pathway. Eur Rev
Med Pharmacol Sci. 22:2321–2327. 2018.PubMed/NCBI
|
|
34
|
Cui S, Wang J, Wu Q, Qian J, Yang C and Bo
P: Genistein inhibits the growth and regulates the migration and
invasion abilities of melanoma cells via the FAK/paxillin and MAPK
pathways. Oncotarget. 8:21674–21691. 2017.PubMed/NCBI
|
|
35
|
Du T, Qu Y, Li J, Li H, Su L, Zhou Q, Yan
M, Li C, Zhu Z and Liu B: Maternal embryonic leucine zipper kinase
enhances gastric cancer progression via the FAK/Paxillin pathway.
Mol Cancer. 13:1002014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lu XS, Sun W, Ge CY, Zhang WZ and Fan YZ:
Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin
signaling pathways to tumor growth and vasculogenic mimicry of
gallbladder carcinomas. Int J Oncol. 42:2103–2115. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu YL, Lu S, Szeto KW, Sun J, Wang Y,
Lasheras JC and Chien S: FAK and paxillin dynamics at focal
adhesions in the protrusions of migrating cells. Sci Rep.
4:60242014. View Article : Google Scholar : PubMed/NCBI
|
